Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Phase”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05248997
What this trial is testing

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

Who this might be right for
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Pfizer 261
Testing effectiveness (Phase 2)Study completedNCT01056523
What this trial is testing

Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Jewish General Hospital 29
Testing effectiveness (Phase 2)Study completedNCT06437223
What this trial is testing

Study of Xiflam™ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC)

Who this might be right for
Long COVID
Inflammx Therapeutics Inc 16
Early research (Phase 1)Active Not RecruitingNCT05362773
What this trial is testing

MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Leukemia, Acute MyeloidMyelodysplastic SyndromesClassical Hodgkin Lymphoma+5 more
MacroGenics 130
Testing effectiveness (Phase 2)Study completedNCT00315705
What this trial is testing

Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaRelapsed Leukemia
Genzyme, a Sanofi Company 50
Testing effectiveness (Phase 2)Study completedNCT03065400
What this trial is testing

PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

Who this might be right for
Chronic Phase MyelofibrosisPrimary MyelofibrosisPost-essential Thrombocythemia Myelofibrosis+1 more
John Mascarenhas 10
Testing effectiveness (Phase 2)Study completedNCT00927836
What this trial is testing

AXIS 2: AX200 for the Treatment of Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
Sygnis Bioscience GmbH & Co KG 328
Post-approval studies (Phase 4)UnknownNCT04252963
What this trial is testing

Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)

Who this might be right for
Acute Upper Respiratory InfectionAcute Bronchitis
Hanmi Pharmaceutical Company Limited 346
Testing effectiveness (Phase 2)Study completedNCT00047021
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Case Comprehensive Cancer Center 3
Large-scale testing (Phase 3)Study completedNCT03840616
What this trial is testing

Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast Infections

Who this might be right for
Recurrent Vulvovaginal Candidiasis
Mycovia Pharmaceuticals Inc. 219
Early research (Phase 1)Ended earlyNCT05038644
What this trial is testing

XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia

Who this might be right for
Acute Myeloid LeukemiaT Cell Acute Lymphoblastic LeukemiaT Cell Lymphoblastic Lymphoma
Ehab L Atallah 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04789044
What this trial is testing

Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)

Who this might be right for
Peripheral Nerve Injuries
Major Extremity Trauma Research Consortium 40
Not applicableStudy completedNCT00996047
What this trial is testing

S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
SWOG Cancer Research Network 3,341
Testing effectiveness (Phase 2)Study completedNCT03055338
What this trial is testing

An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)

Who this might be right for
Schizophrenia, Acute Episode
Merck Sharp & Dohme LLC 224
Testing effectiveness (Phase 2)Study completedNCT04055844
What this trial is testing

Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS

Who this might be right for
Acute Myeloid LeukemiaMyeloid and Monocytic LeukemiaMyelodysplastic Syndromes
Masonic Cancer Center, University of Minnesota 14
Testing effectiveness (Phase 2)Study completedNCT00609609
What this trial is testing

Photopheresis for the Treatment of Acute Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
M.D. Anderson Cancer Center 81
Early research (Phase 1)Looking for participantsNCT07250087
What this trial is testing

Asciminib Maintenance Therapy Following alloHCT or CAR T to Prevent Relapse in Adults With Ph+ALL

Who this might be right for
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
H. Lee Moffitt Cancer Center and Research Institute 36
Testing effectiveness (Phase 2)Study completedNCT06865352
What this trial is testing

Safety and Preliminary Efficacy of Donor-derived Anti-leukemia Cytotoxic T Lymphocytes for the Prevention of Leukemia Relapse in Children Given Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia ALLAcute Myeloid Leukemia (AML)
Fondazione IRCCS Policlinico San Matteo di Pavia 15
Testing effectiveness (Phase 2)Study completedNCT03452228
What this trial is testing

Safety and Efficacy Following Repeat-Dose of Evinacumab (Anti-ANGPTL3) in Patients With Severe Hypertriglyceridemia (sHTG) at Risk for Acute Pancreatitis

Who this might be right for
Severe Hypertriglyceridemia (sHTG)
Regeneron Pharmaceuticals 52
Large-scale testing (Phase 3)Enrolling By InvitationNCT06544109
What this trial is testing

Venetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients

Who this might be right for
Acute Promyelocytic Leukemia
The First Affiliated Hospital of Soochow University 98
Next Page